Long-term studies in depression - Relapse versus remission. Long-term studies with antidepressants - Methodological aspects for consideration

European Psychiatry

Volumn 11, Issue 3, 1996, Pages 116-119

  Pedersen, V ^a  

^a H LUNDBECK A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; MONOAMINE OXIDASE INHIBITOR; PAROXETINE; PHENELZINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

DEPRESSION; DRUG EFFICACY; HUMAN; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RECURRENCE RISK; REVIEW;

EID: 0029954414     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/0924-9338(96)85174-1     Document Type: Article

References (20)

1. Björk K. The efficacy of zimilidine in preventing depressive episodes in recurrent major depressive disorders: a double-blind placebo-controlled study. Acta Psychiatr Scand 1983;68 (suppl 308):182-9
2. Coppen A, Ghose K, Montgomery S et al. Continuation therapy with amitriptyline in depression. Br J Psychiatry 1978;133:28-33
3. Doogan DP, Caillard V. Sertraline in the prevention of depression. Brit J Psychiatr 1992;160:217-22
4. Frank E, Kupfer DJ, Perel JM et al. Comparison of full-dose vs half-dose pharmacotherapy in the maintenance treatment of recurrent depression. J Affective Disord 1993;27:139-145
5. Georgotas A, McCue RE, Cooper TB. A placebo-controlled comparison of nortriptyline and phenelzine in maintenance therapy of elderly depressed patients. Arch Gen Psychiatry 1989;46 (suppl 8):46-51
6. Greenhouse JB, Stangl D, Kupfer DJ, Prien RF. Methodologic issues in maintenance therapy clinical trials. Arch Gen Psychiatry 1991;48:313-8
7. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6:278-96
8. Klerman GL, Dimascio A, Weissman M et al. Treatment of depression by drugs and psychotherapy. Am J Psychiatry 1974;131:186-91
9. Kupfer DJ. Lessons to be learned from long-term treatment of affective disorders: potential utility in panic disorder. J Clin Psychiatry 1991;52 (suppl 2):12-6
10. Kupfer DJ, Frank E. The minimum length of treatment for recovery. In: Mongtomery SA, Rouillon F, eds. The Long Term Treatment of Depression. Chichester: John Wiley, 1992;33-52
11. Mindham RHS, Howland C, Shepherd M. An evaluation of continuation therapy with tricyclic antidepressants in depressive illness. Psychol Med 1973;3:5-17
12. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Brit J Psychiatry 1979;134:382-9
13. Montgomery SA, Dunbar GC. Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression. Int Clin Psychopharmacol 1993;8:189-95
14. Montgomery SA, Montgomery DB. Prophylactic treatment in recurrent unipolar depression. In: Montgomery SA, Rouillon F, eds. The Long Term Treatment of Depression. Chichester: John Wiley, 1992;53-80
15. Montgomery SA, Rasmussen JGC, Tanghøj P. A 24-week study of 20 mg citalopram, 40 mg citalopram, and placebo in the prevention of relapse of major depression. Int Clin Psychopharmacol 1993;8:181-8
16. Prien RF, Klett CJ, Caffey EM. Lithium carbonate and imipramine in the prevention of affective episodes. Arch Gen Psychiatry 1973;29:420-5
17. Robinson DS, Lerfald SC, Bennett B et al Continuation and maintenance treatment of major depression with the monoamine oxidase inhibitor phenelzine: a double blind placebo controlled discontinuation study. Psychopharmacol Bull 1991;27:31-9
18. Rouillon F, Phillips R, Serrurier D, Ansarte E, Gerard MJ. Rechutes de depression unipolaire et efficacite de la maprotiline. Encephale 1989;15:527-34
19. Seager CP, Bird RL. Imipramine with electrical treatment in depression: a controlled trial. J Ment Sci 1962;108:704-7
20. Stein M, Rickels K, Weise CC. Maintenance therapy with amitriptyline: a controlled trial. Am J Psychiatry 1980;137:370-1